Insider Sale: Director at TGTX sold 5,000 Shares

Generated byAinvest NewsReviewed byThe Newsroom

Monday, Sep 14, 2026 8:17 pm ET1min read

TGTX--

Aime Summary

- Tg TherapeuticsTGTX-- director Charney Laurence N sold 5,000 shares ($274,800) on Sep 10, 2026, representing 2.9% of their holdings.

- This marked the sole insider transaction in TGTXTGTX-- over six months, with no purchases recorded during the period.

- The company reported $445.3MMMM-- H1 2026 revenue, a 69.94% year-over-year increase, while the director retains 168,640 shares post-sale.

Charney Laurence N, a Director at Tg TherapeuticsTGTX-- (NASDAQ: TGTX), sold 5,000 shares of the company on Sep 10, 2026 for an estimated $274,800. This transaction represented approximately 2.9% of their holdings in this class of stock. The sale leaves them with a remaining position of 168,640 shares in TGTXTGTX--.

Tg Therapeutics Insider Trading Activity

Over the past six months, insiders at Tg Therapeutics have executed just one open-market trade in TGTX. All of that activity consisted of sales, with zero purchases recorded.

The following details summarize the recent insider trading activity for TGTX over the last six months:

Charney Laurence N sold 5,000 shares for an estimated $274,800.

Tg Therapeutics Revenue

Tg Therapeutics posted revenues of $445.3M in H1 2026. That figure marks a 69.94% increase compared to the same period last year.

Ainvest News

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue